Cargando…
A phase I dose-finding design with incorporation of historical information and adaptive shrinking boundaries
Although many novel phase I designs have been developed in recent years, few studies have discussed how to incorporate external information into dose-finding designs. In this paper, we first propose a new method for developing a phase I design, Bayesian optimal interval design (BOIN)[Liu S et al. (2...
Autores principales: | Li, Chen, Pan, Haitao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451661/ https://www.ncbi.nlm.nih.gov/pubmed/32853204 http://dx.doi.org/10.1371/journal.pone.0237254 |
Ejemplares similares
-
A clinical phase I dose-finding design with adaptive shrinking boundaries for drug combination trials
por: Li, Zhaohang, et al.
Publicado: (2023) -
An adaptive gBOIN design with shrinkage boundaries for phase I dose-finding trials
por: Mu, Rongji, et al.
Publicado: (2021) -
Practical considerations for the implementation of adaptive designs for oncology Phase I dose-finding trials
por: Wei, Lai, et al.
Publicado: (2019) -
On our rapidly shrinking capacity to comply with the planetary boundaries on climate change
por: Mathias, Jean-Denis, et al.
Publicado: (2017) -
On the Stability of MHD Boundary Layer Flow over a Stretching/Shrinking Wedge
por: Awaludin, Izyan Syazana, et al.
Publicado: (2018)